Subgroup analysis was conducted to further explore the stratification value of serum AG for primary endpoints among different patient subgroups, encompassing sex, age, BMI, hypertension, congestive heart failure, cerebrovascular disease, moderate to severe liver disease, metastatic solid tumors and insulin use(Figs 4A and 4B). The gene discussed is INS; the disease is liver disorder.